AKAP121 focuses distinct signaling events from membrane to mitochondria by binding and targeting cAMP-dependent protein kinase (PKA), protein tyrosine phosphatase (PTPD1), and mRNA. We find that AKAP121 also targets src tyrosine kinase to mitochondria via PTPD1. AKAP121 increased src-dependent phosphorylation of mitochondrial substrates and enhanced the activity of cytochrome c oxidase, a component of the mitochondrial respiratory chain. Mitochondrial membrane potential and ATP oxidative synthesis were enhanced by AKAP121 in an src-and PKA-dependent manner. Finally, siRNA-mediated silencing of endogenous AKAP121 drastically impaired synthesis and accumulation of mitochondrial ATP. These findings indicate that AKAP121, through its role in enhancing cAMP and tyrosine kinase signaling to distal organelles, is an important regulator in mitochondrial metabolism. INTRODUCTIONProtein kinase A (PKA) is an essential mediator in most cAMP-dependent signaling pathways. A family of proteins named A-kinase anchor proteins (AKAPs) has been identified that enhance cAMP-dependent PKA signaling pathways (Rubin, 1994;Gray et al., 1998;McKnight et al., 1998;Feliciello et al., 2001;Houslay and Adams, 2003;Tasken and Aandahl, 2004;Taylor et al., 2004;Wong and Scott, 2004). AKAP121 (also called D-AKAP1), AKAP149, and AKAP84 arise from a single gene by alternative pre-mRNA splicing (Lin et al., 1995;Trendelenburg et al., 1996;Chen et al., 1997;Huang et al., 1997Huang et al., , 1999Furusawa et al., 2002). AKAP121 and AKAP84 tether PKA to the mitochondrial outer surface. This localization is mediated by the interaction of AKAP121 and AKAP84 with ␤ tubulin, an integral component of mitochondrial outer membrane (Cardone et al., 2002). AKAP121 is widely expressed in several tissues and its accumulation is regulated at the transcriptional level by the cAMP/PKA pathway (Feliciello et al., 1998). Anchoring of PKA to mitochondria supports cAMP signaling and suppresses apoptosis (Harada et al., 1999;Affaitati et al., 2003). AKAP121, via a KH domain at its COOH-terminus, binds at least two mRNAs that encode mitochondrial proteins Ranganathan et al., 2005). This multicomponent system, reminiscent of other AKAP complexes at cell membranes, ensures efficient translation and import of nuclear-encoded mitochondrial proteins. It is suggested that PKA may phosphorylate some of these proteins cotranslationally, as well as acting on AKAP121 itself to regulate the stability of the RNA-AKAP121 complex Feliciello et al., 2005).In addition, AKAP121 and AKAP84 bind the central core of PTPD1, a classical nonreceptor protein tyrosine phosphatase (Moller et al., 1994). PTPD1 binds to and activates src, enhancing EGF-dependent mitogenic signaling (Cardone et al., 2004). By translocating PTPD1 to the outer membrane of mitochondria, AKAP121 inhibits PTPD1-dependent EGF signaling to the nucleus. These data suggest a model whereby AKAP121, by targeting PTPD1/src complex to mitochondria, may shift the focus of tyrosine kinase signaling from membrane to specific distal...

No abstract

A-kinase anchor protein 121 (AKAP121) and its spliced isoform AKAP84 anchor protein kinase A (PKA) to the outer membrane of mitochondria, focusing and enhancing cyclic AMP signal transduction to the organelle. We find that AKAP121/84 also binds PTPD1, a src-associated protein tyrosine phosphatase. A signaling complex containing AKAP121, PKA, PTPD1, and src is assembled in vivo. PTPD1 activates src tyrosine kinase and increases the magnitude and duration of epidermal growth factor (EGF) signaling. EGF receptor phosphorylation and downstream activation of ERK 1/2 and Elk1-dependent gene transcription are enhanced by PTPD1. Expression of a PTPD1 mutant lacking catalytic activity inhibits src and downregulates ERK 1/2 but does not affect the activity of c-Jun N-terminal kinase 1/2 and p38alpha mitogen-activated protein kinase. AKAP121 binds to and redistributes PTPD1 from the cytoplasm to mitochondria and inhibits EGF signaling. Our findings indicate that PTPD1 is a novel positive regulator of src signaling and a key component of the EGF transduction pathway. By binding and/or targeting the phosphatase on mitochondria, AKAP121 modulates the amplitude and persistence of src-dependent EGF transduction pathway. This represents the first example of physical and functional interaction between AKAPs and a protein tyrosine phosphatase.

No abstract

A-kinase anchor protein 121 (AKAP121) assembles a multivalent signalling complex on the outer mitochondrial membrane that controls persistence and amplitude of cAMP and src signalling to mitochondria, and plays an essential role in oxidative metabolism and cell survival. Here, we show that AKAP121 levels are regulated posttranslationally by the ubiquitin/proteasome pathway. Seven In-Absentia Homolog 2 (Siah2), an E3-ubiquitin ligase whose expression is induced in hypoxic conditions, formed a complex and degraded AKAP121. In addition, we show that overexpression of Siah2 or oxygen and glucose deprivation (OGD) promotes Siah2-mediated ubiquitination and proteolysis of AKAP121. Upregulation of Siah2, by modulation of the cellular levels of AKAP121, significantly affects mitochondrial activity assessed as mitochondrial membrane potential and oxidative capacity. Also during cerebral ischaemia, AKAP121 is degraded in a Siah2-dependent manner. These findings reveal a novel mechanism of attenuation of cAMP/PKA signaling, which occurs at the distal sites of signal generation mediated by proteolysis of an AKAP scaffold protein. By regulating the stability of AKAP121-signalling complex at mitochondria, cells efficiently and rapidly adapt oxidative metabolism to fluctuations in oxygen availability.

No abstract

Activation of G-protein-coupled receptors (GPCRs) mobilizes compartmentalized pulses of cyclic AMP. The main cellular effector of cAMP is protein kinase A (PKA), which is assembled as an inactive holoenzyme consisting of two regulatory (R) and two catalytic (PKAc) subunits. cAMP binding to R subunits dissociates the holoenzyme and releases the catalytic moiety, which phosphorylates a wide array of cellular proteins. Reassociation of PKAc and R components terminates the signal. Here we report that the RING ligase praja2 controls the stability of mammalian R subunits. Praja2 forms a stable complex with, and is phosphorylated by, PKA. Rising cAMP levels promote praja2-mediated ubiquitylation and subsequent proteolysis of compartmentalized R subunits, leading to sustained substrate phosphorylation by the activated kinase. Praja2 is required for efficient nuclear cAMP signalling and for PKA-mediated long-term memory. Thus, praja2 regulates the total concentration of R subunits, tuning the strength and duration of PKA signal output in response to cAMP.

PTPD1 is a cytosolic nonreceptor tyrosine phosphatase and a positive regulator of the Src-epidermal growth factor transduction pathway. We show that PTPD1 localizes along actin filaments and at adhesion plaques. PTPD1 forms a stable complex via distinct molecular modules with actin, Src tyrosine kinase, and focal adhesion kinase (FAK), a scaffold protein kinase enriched at adhesion plaques. Overexpression of PTPD1 promoted cell scattering and migration, short hairpin RNA-mediated silencing of endogenous PTPD1, or expression of PTPD1 mutants lacking either catalytic activity (PTPD1 C1108S ) or the FERM domain (PTPD1 ⌬1-325 ) significantly reduced cell motility. PTPD1 and Src catalytic activities were both required for epidermal growth factor-induced FAK autophosphorylation at its active site and for downstream propagation of ERK1/2 signaling. Our findings demonstrate that PTPD1 is a component of a multivalent scaffold complex nucleated by FAK at specific intracellular sites. By modulating Src-FAK signaling at adhesion sites, PTPD1 promotes the cytoskeleton events that induce cell adhesion and migration.